ANTI-FACTOR XA TESTING FOR QUANTIFYING ANTICOAGULANT EFFECT DUE TO ORAL DIRECT XA INHIBITORS

被引：0
|
作者：
Beyer, Jacob
Trujillo, Toby
Kiser, Tyree
机构：
来源：
CRITICAL CARE MEDICINE | 2015年 / 43卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
588
引用
收藏
页数：1
相关论文
共 50 条
  • [21] EVALUATION OF ANTI-FACTOR XA ASSAYS FOR MONITORING INDIRECT XA INHIBITORS USING EXTERNAL QUALITY DATA
    Meijer, Piet
    Hollestelle, Martine
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 : 116 - 116
  • [22] Thrombin inhibitors and anti-factor Xa agents in the treatment of arterial occlusion
    Klauss, V.
    Spannagl, M.
    [J]. CURRENT DRUG TARGETS, 2006, 7 (10) : 1285 - 1290
  • [23] Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
    Hillarp, Andreas
    Strandberg, Karin
    Baghaei, Fariba
    Blixter, Inger Fagerberg
    Gustafsson, Kerstin M.
    Lindahl, Tomas L.
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (7-8): : 575 - 583
  • [24] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ono, Ryohei
    Nishimura, Kazutaka
    Takahashi, Hidehisa
    Hori, Yasuhiko
    Fukushima, Kenichi
    Kobayashi, Yoshio
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 323 - 336
  • [25] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors
    Ryohei Ono
    Kazutaka Nishimura
    Hidehisa Takahashi
    Yasuhiko Hori
    Kenichi Fukushima
    Yoshio Kobayashi
    [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
  • [26] A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti-Factor Xa Concentrations
    Levito, Marissa N.
    Coons, James C.
    Verrico, Margaret M.
    Szymkowiak, Adrienne
    Legler, Brianna
    Dueweke, Eric J.
    Kane-Gill, Sandra L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (05) : 618 - 623
  • [27] CLINICAL SIGNIFICANCE OF ANTI-FACTOR XA ASSAY
    ODEGARD, OR
    ABILDGAARD, U
    [J]. ACTA MEDICA SCANDINAVICA, 1978, : 19 - 19
  • [28] Anticoagulation via anti-Factor Xa inhibition
    Wiles, N
    Hunt, BJ
    [J]. LUPUS, 2006, 15 (03) : 167 - 171
  • [29] The edoxaban, a new oral direct and specific anti-Xa anticoagulant
    Chleir, F.
    [J]. PHLEBOLOGIE-ANNALES VASCULAIRES, 2011, 64 (04): : 73 - 73
  • [30] Direct oral anti-Xa inhibitors and vaginal bleeding
    Ferreira, Melanie
    [J]. LANCET HAEMATOLOGY, 2016, 3 (10): : E451 - E452
12345